The Fc-mediated effector functions of a potent SARS-CoV-2 neutralizing antibody, SC31, isolated from an early convalescent COVID-19 patient, are essential for the optimal therapeutic efficacy of the antibodyConrad En Zuo Chan, Brendon J. Hanson|PLoS ONE|2021Cited by 106
Induction of Human T-cell and Cytokine Responses Following Vaccination with a Novel Influenza VaccineDavid Skibinski, John E. Connolly, Yuan Zhu et al.|Scientific Reports|2018Cited by 40